Stock Movers: Eli Lilly, Qualcomm, and Carrier Global Discussed

Eli Lilly's Weight-Loss Drug Setback

• 📉 Eli Lilly shares experienced a significant intraday drop, their largest since October, following CVS Health's decision to remove Zepbound from its preferred drug list.
• 🎯 This move by CVS will make rival Novo Nordisk's Wegovy more widely available, impacting Eli Lilly's market position in the lucrative weight-loss drug sector.
• ⚖️ Despite the setback, Eli Lilly maintained its full-year sales guidance, but investors were reportedly underwhelmed by the growth outlook.
• 🔄 The weight-loss drug market is characterized by intense competition, with recent deals from Novo Nordisk and Eli Lilly aimed at different customer segments and pricing strategies.

Qualcomm's Tepid Revenue Forecast

• 📉 Qualcomm shares fell after issuing a revenue forecast that fell slightly below analyst estimates, raising concerns about demand for its smartphone chips.
• 📊 The company projected revenue between $9.9 billion and $10.7 billion for the period ending in June, with the midpoint missing the average analyst expectation.
• ⚠️ The chipmaker's performance is under scrutiny amid ongoing tariffs and global trade tensions, which could impact demand for its products.

Carrier Global Mitigates Tariff Impact

• 📈 Carrier Global Corp. shares rose significantly after the company announced it is fully mitigating the impact of tariffs through price increases and supply chain actions.
• 💰 The HVAC manufacturer expects to offset approximately $300 million in tariff exposure primarily through price adjustments, boosting its full-year profit outlook.
• 🗣️ CEO Dave Gitlin highlighted the company's ability to manage tariff challenges, a strategy that has resonated positively with investors, leading to a substantial stock price jump.
• 🏠 While beneficial for shareholders, the price increases may lead to higher costs for consumers purchasing HVAC equipment.
• 📊 Carrier Global's stock, which was previously down year-to-date, saw its biggest jump since April 2020, reflecting investor confidence in its strategy.